Sittner & Nelson, LLC Astrazeneca PLC Transaction History
Sittner & Nelson, LLC
- $225 Million
- Q4 2024
A detailed history of Sittner & Nelson, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Sittner & Nelson, LLC holds 11,225 shares of AZN stock, worth $841,089. This represents 0.33% of its overall portfolio holdings.
Number of Shares
11,225
Previous 10,975
2.28%
Holding current value
$841,089
Previous $855,000
14.04%
% of portfolio
0.33%
Previous 0.39%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,368Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.52 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.07 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.81 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.78 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.8 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $232B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...